American Association for Cancer Research Annual Meeting
American Association for Cancer Research Annual Meeting
April 17, 2016
2 min watch
Save

VIDEO: Liquid biopsies valuable but will not eliminate need to assess tumor tissue

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEW ORLEANS — Filip Janku, MD, PhD, medical oncologist at The University of Texas MD Anderson Cancer Center, spoke to HemOnc Today about the clinical utility of liquid biopsies.

Janku discussed how liquid biopsies can help detect underlying genomic alterations, monitor patients’ response to therapies and enhance understanding of therapy resistance. However, they likely will remain complimentary to tissue biopsies, Janku said.

“I personally don’t believe that liquid biopsies will replace cancer tissue,” Janku told HemOnc Today. “Cancer biopsies and analysis of the cancer tissue will remain important, but I can also see liquid biopsies as another modality that will simply help us get more information that will help us to treat our patients better and in a more informational way.”